Suppr超能文献

放射性合成与脑内瞬时受体电位经典型 5 放射性示踪剂的评价。

Radiosynthesis and Evaluation of a C-11 Radiotracer for Transient Receptor Potential Canonical 5 in the Brain.

机构信息

Department of Radiology, Washington University School of Medicine, St. Louis, MO, 63110, USA.

Center for the Study of Itch and Sensory Disorders, Department of Anesthesiology, Washington University School of Medicine, St. Louis, MO, 63110, USA.

出版信息

Mol Imaging Biol. 2023 Apr;25(2):334-342. doi: 10.1007/s11307-022-01760-y. Epub 2022 Aug 11.

Abstract

PURPOSE

TRPC5 belongs to the mammalian superfamily of transient receptor potential (TRP) Ca-permeable cationic channels and it has been implicated in various CNS disorders. As part of our ongoing interest in the development of a PET radiotracer for imaging TRPC5, herein, we explored the radiosynthesis, and in vitro and in vivo evaluation of a new C-11 radiotracer [C]HC070 in rodents and nonhuman primates.

PROCEDURES

[C]HC070 was radiolabeled utilizing the corresponding precursor and [C]CHI via N-methylation protocol. Ex vivo biodistribution study of [C]HC070 was performed in Sprague-Dawley rats. In vitro autoradiography study was conducted for the rat brain sections to characterize the radiotracer distribution in the brain regionals. MicroPET brain imaging studies of [C]HC070 were done for 129S1/SvImJ wild-type mice and 129S1/SvImJ TRPC5 knockout mice for 0-60-min dynamic data acquisition after intravenous administration of the radiotracer. Dynamic PET scans (0-120 min) for the brain of cynomolgus male macaques were performed after the radiotracer injection.

RESULTS

[C]HC070 was efficiently prepared with good radiochemical yield (45 ± 5%, n = 15), high chemical and radiochemical purity (> 99%), and high molar activity (320.6 ± 7.4 GBq/μmol, 8.6 ± 0.2 Ci/μmol) at the end of bombardment (EOB). Radiotracer [C]HC070 has good solubility in the aqueous dose solution. The ex vivo biodistribution study showed that [C]HC070 had a quick rat brain clearance. Autoradiography demonstrated that [C]HC070 specifically binds to TRPC5-enriched regions in rat brain. MicroPET study showed the peak brain uptake (SUV value) was 0.63 in 129S1/SvImJ TRPC5 knockout mice compared to 1.13 in 129S1/SvImJ wild-type mice. PET study showed that [C]HC070 has good brain uptake with maximum SUV of ~ 2.2 in the macaque brain, followed by rapid clearance.

CONCLUSIONS

Our data showed that [C]HC070 is a TRPC5-specific radiotracer with high brain uptake and good brain washout pharmacokinetics in both rodents and nonhuman primates. The radiotracer is worth further investigating of its suitability to be a PET radiotracer for imaging TRPC5 in animals and human subjects in vivo.

摘要

目的

TRPC5 属于哺乳动物瞬时受体电位 (TRP) 钙通透性阳离子通道超家族,它与各种中枢神经系统疾病有关。作为我们开发用于成像 TRPC5 的 PET 示踪剂的持续兴趣的一部分,在此,我们探索了新型 C-11 示踪剂 [C]HC070 在啮齿动物和非人类灵长类动物中的放射性合成、体外和体内评估。

过程

利用相应的前体和 [C]CHI 通过 N-甲基化方案对 [C]HC070 进行放射性标记。在 Sprague-Dawley 大鼠中进行 [C]HC070 的离体生物分布研究。对大鼠脑切片进行体外放射自显影研究,以表征示踪剂在脑区域的分布。对 129S1/SvImJ 野生型小鼠和 129S1/SvImJ TRPC5 敲除小鼠进行 [C]HC070 的 microPET 脑成像研究,在静脉注射示踪剂后进行 0-60 分钟的动态数据采集。在放射性示踪剂注射后对食蟹猴雄性猕猴的大脑进行动态 PET 扫描(0-120 分钟)。

结果

[C]HC070 的放射性合成效率高,放射化学产率为 45±5%(n=15),化学和放射化学纯度高(>99%),摩尔活度高(320.6±7.4GBq/μmol,8.6±0.2Ci/μmol)在终点(EOB)。示踪剂 [C]HC070 在水性剂量溶液中具有良好的溶解度。离体生物分布研究表明,[C]HC070 在大鼠脑中具有快速清除作用。放射自显影显示 [C]HC070 特异性结合大鼠脑中富含 TRPC5 的区域。microPET 研究表明,129S1/SvImJ TRPC5 敲除小鼠的脑摄取峰值(SUV 值)为 0.63,而 129S1/SvImJ 野生型小鼠为 1.13。PET 研究表明,[C]HC070 在猕猴大脑中具有良好的脑摄取,最大 SUV 值约为 2.2,随后清除迅速。

结论

我们的数据表明,[C]HC070 是一种 TRPC5 特异性示踪剂,在啮齿动物和非人类灵长类动物中具有高脑摄取和良好的脑洗脱药代动力学。该示踪剂值得进一步研究,以确定其是否适合作为体内成像 TRPC5 的 PET 示踪剂在动物和人体中的适用性。

相似文献

1
Radiosynthesis and Evaluation of a C-11 Radiotracer for Transient Receptor Potential Canonical 5 in the Brain.
Mol Imaging Biol. 2023 Apr;25(2):334-342. doi: 10.1007/s11307-022-01760-y. Epub 2022 Aug 11.
2
Development of a carbon-11 PET radiotracer for imaging TRPC5 in the brain.
Org Biomol Chem. 2019 Jun 5;17(22):5586-5594. doi: 10.1039/c9ob00893d.
3
Radiosynthesis and characterization of a carbon-11 PET tracer for receptor-interacting protein kinase 1.
Nucl Med Biol. 2022 Jul-Aug;110-111:18-27. doi: 10.1016/j.nucmedbio.2022.04.006. Epub 2022 Apr 19.
4
Radiosynthesis and ex vivo evaluation of [11C]-SIB-1553A as a PET radiotracer for beta4 selective subtype nicotinic acetylcholine receptor.
Nucl Med Biol. 2008 Apr;35(3):377-85. doi: 10.1016/j.nucmedbio.2007.11.011. Epub 2008 Jan 30.
5
Radiosynthesis and initial preclinical evaluation of [C]AZD1283 as a potential P2Y12R PET radiotracer.
Nucl Med Biol. 2022 Nov-Dec;114-115:143-150. doi: 10.1016/j.nucmedbio.2022.05.001. Epub 2022 May 20.
7
Metal Protein-Attenuating Compound for PET Neuroimaging: Synthesis and Preclinical Evaluation of [C]PBT2.
Mol Pharm. 2018 Feb 5;15(2):695-702. doi: 10.1021/acs.molpharmaceut.7b00936. Epub 2018 Jan 22.
9
Carbon-11 labeled papaverine as a PET tracer for imaging PDE10A: radiosynthesis, in vitro and in vivo evaluation.
Nucl Med Biol. 2010 May;37(4):509-16. doi: 10.1016/j.nucmedbio.2009.12.012. Epub 2010 Mar 6.
10
Synthesis and preclinical evaluation of [11C-carbonyl]PF-04457845 for neuroimaging of fatty acid amide hydrolase.
Nucl Med Biol. 2013 Aug;40(6):740-6. doi: 10.1016/j.nucmedbio.2013.04.008. Epub 2013 May 31.

引用本文的文献

1
Two F-18 radiochemistry methods to synthesize a promising transient receptor potential canonical 5 (TRPC5) radioligand.
J Fluor Chem. 2024 Nov;280. doi: 10.1016/j.jfluchem.2024.110367. Epub 2024 Oct 22.
2
Development and Optimization of C-Labeled Radiotracers: A Review of the Modern Quality Control Design Process.
ACS Pharmacol Transl Sci. 2023 Oct 11;6(11):1616-1631. doi: 10.1021/acsptsci.3c00200. eCollection 2023 Nov 10.

本文引用的文献

1
Structural basis for human TRPC5 channel inhibition by two distinct inhibitors.
Elife. 2021 Mar 8;10:e63429. doi: 10.7554/eLife.63429.
3
Synthesis and Characterization of a Specific Iodine-125-Labeled TRPC5 Radioligand.
ChemMedChem. 2020 Oct 5;15(19):1854-1860. doi: 10.1002/cmdc.202000339. Epub 2020 Sep 2.
4
TRPC channels: Structure, function, regulation and recent advances in small molecular probes.
Pharmacol Ther. 2020 May;209:107497. doi: 10.1016/j.pharmthera.2020.107497. Epub 2020 Jan 28.
5
Development of a carbon-11 PET radiotracer for imaging TRPC5 in the brain.
Org Biomol Chem. 2019 Jun 5;17(22):5586-5594. doi: 10.1039/c9ob00893d.
6
Review of Transient Receptor Potential Canonical (TRPC5) Channel Modulators and Diseases.
J Med Chem. 2019 Sep 12;62(17):7589-7602. doi: 10.1021/acs.jmedchem.8b01954. Epub 2019 Apr 17.
7
Reducing the Lipophilicity of Perfluoroalkyl Groups by CF-F/CF-Me or CF/CH Exchange.
J Med Chem. 2018 Dec 13;61(23):10602-10618. doi: 10.1021/acs.jmedchem.8b01222. Epub 2018 Nov 28.
8
Treatment with HC-070, a potent inhibitor of TRPC4 and TRPC5, leads to anxiolytic and antidepressant effects in mice.
PLoS One. 2018 Jan 31;13(1):e0191225. doi: 10.1371/journal.pone.0191225. eCollection 2018.
9
Transient receptor potential canonical 5 (TRPC5) protects against pain and vascular inflammation in arthritis and joint inflammation.
Ann Rheum Dis. 2017 Jan;76(1):252-260. doi: 10.1136/annrheumdis-2015-208886. Epub 2016 May 10.
10
Considerations in the Development of Reversibly Binding PET Radioligands for Brain Imaging.
Curr Med Chem. 2016;23(18):1818-69. doi: 10.2174/0929867323666160418114826.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验